CLINICAL CASE OF LUNG SARCOIDOSIS WITH INTEGRATED INTERDISCIPLINARY DIAGNOSIS VERIFICATION

Authors

  • N. L. Glushko Ivano-Frankivsk National Medical University
  • Ya. Ya. Sikorin Ivano-Frankivsk National Medical University
  • V. M. Matskevich Ivano-Frankivsk National Medical University
  • T. L. Lenchuk Ivano-Frankivsk National Medical University
  • Yu. O. Mytsyk Danylo Halytskyi Lviv National Medical University
  • V. M. Rizhik Ivano-Frankivsk National Medical University

DOI:

https://doi.org/10.11603/1811-2471.2020.v.i1.11070

Keywords:

sarcoidosis, bronchoscopy, computed tomography, determination of angiotensin-converting enzyme, histological examination of lymph node, glucocorticosteroid therapy

Abstract

The idiopathic onset, the variety of clinical manifestations, the inability to predict the course requires the maximum consideration of all confirmed cases of sarcoidosis in order to accurately select a therapy strategy.

Material and Methods. Description of diagnostic and verification pulmonary sarcoidosis using different methods of examination before and after treatment for objective reporting capabilities of each type of diagnosis.

Results. The clinical case of sarcoidosis in a 45 year-old patient is considered, the importance of combining modern methods of examination, including computed tomography, polymerase-chain reaction in the study of sputum, determination of angiotensin-converting enzyme, video bronchoscopy, and biopsy of lymph node are demonstrated.

Conclusions. The use of a comprehensive approach in the diagnosis of pulmonary sarcoidosis can not only verify but also trace the dynamics of the pathological process under the influence of prescribed therapeutic measures and optimally adjust the dosage of glucocorticosteroid therapy.

References

Huppertz, C., Jäger, B., Wieczorek, G., Engelhard, P., Oliver, S.J., Bauernfeind F-G. et al. (2020). The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation. European Respiratory Journal. Retrieved from: https://doi.org/10.1183/13993003.00119-2019. DOI: https://doi.org/10.1183/13993003.00119-2019

Hostettler, K.E., Baty, F., Kleiner, R., Junker, L., Tamm, M., Brutsche, M.H. (2018). Bosentan for patients with steroid-resistant pulmonary sarcoidosis: A randomised controlled trial. Swiss Medical Week, 148. Retrieved from: https://doi.org/10.4414/smw.2018.14677. DOI: https://doi.org/10.4414/smw.2018.14677

Patterson, K.C., & Chen, E.S. (2018). The pathogenesis of pulmonary sarcoidosis and implications for treatment. Chest, 153 (6), 1432-1442. Retrieved from: https://doi.org/10.1016/j.chest.2017.11.030. DOI: https://doi.org/10.1016/j.chest.2017.11.030

Crotty, S. (2019). T follicular helper cell biology: A decade of discovery and diseases. Immunity, 50 (5), 1132-1148. Retrieved from: https://doi.org/10.1016/j.immuni.2019.04.011. DOI: https://doi.org/10.1016/j.immuni.2019.04.011

Lee, G.M., Pope, K., Meek, L., Chung, J.H., Hobbs, S.B., & Walker, C.M. (2020). Sarcoidosis: A diagnosis of exclusion. American Journal of Roentgenology, 214 (1), 50–58. – Retrieved from: https://www.ajronline.org/doi/abs/10.2214/ AJR.19.21436.

Enyedi, A., Csongrádi, A., Altorjay, I.T., Beke, G.L., Váradi, C., Enyedi, E.E. et al. (2020). Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis. Clinica Chimica Acta, 500, 155-162. – Retrieved from: https://doi.org/10.1016/j.cca.2019.10.010. DOI: https://doi.org/10.1016/j.cca.2019.10.010

Magombedze, G., & Marino, S. (2018). Mathematical and computational approaches in understanding the immunobiology of granulomatous diseases. Current Opinion in Systems Biology, 12, 1-11. Retrieved from: https://doi.org/10.1016/j.coisb.2018.07.002. DOI: https://doi.org/10.1016/j.coisb.2018.07.002

Costabel, U., & Hunninghake, G.W. (1999). ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. European Respiratory Journal, 14, 735-737. Retrieved from: https://doi.org/10.1034/ j.1399-3003.1999.14d02.x.

Judson, M.A. (2019). The diagnosis of sarcoidosis. Current Opinion in Pulmonary Medicine, 25 (5), 484-496. Retrieved from: https://doi.org/10.1097/MCP.0000000000000596. DOI: https://doi.org/10.1097/MCP.0000000000000596

Aryal, S., & Nathan, S.D. (2019). Contemporary optimized practice in the management of pulmonary sarcoidosis. Therapeutic Advances in Respiratory Disease, 13. Retrieved from: https://dx.doi.org/10.1177%2F1753466619868935.

Spagnolo, P., Rossi, G., Trisolini, R., Sverzellati, N., Baughman, R.P., Wells, A.U. (2018). Pulmonary sarcoidosis. The Lancet. Respiratory Medicine, 6 (5), 389-402. Retrieved from: https://doi.org/10.1016/S2213-2600(18)30064-X. DOI: https://doi.org/10.1016/S2213-2600(18)30064-X

Published

2020-05-06

How to Cite

Glushko, N. L., Sikorin, Y. Y., Matskevich, V. M., Lenchuk, T. L., Mytsyk, Y. O., & Rizhik, V. M. (2020). CLINICAL CASE OF LUNG SARCOIDOSIS WITH INTEGRATED INTERDISCIPLINARY DIAGNOSIS VERIFICATION. Achievements of Clinical and Experimental Medicine, (1), 63–68. https://doi.org/10.11603/1811-2471.2020.v.i1.11070

Issue

Section

Оригінальні дослідження